Navigation Links
Insulet Appoints Peter J. Devlin as Chief Commercial Officer
Date:8/17/2009

BEDFORD, Mass., Aug. 17 /PRNewswire-FirstCall/ --Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System, today announced the appointment of Peter J. Devlin as Chief Commercial Officer. In this newly created role, Mr. Devlin will lead the Company's Sales and Marketing, Business Development, Clinical Research and Customer Care operations.

"Peter brings a distinguished track record in the diabetes and medical device industries and we are extremely pleased to have him join Insulet's management team," said Duane DeSisto, president & chief executive officer of Insulet. "Peter's proven ability to develop and implement successful commercial strategies globally will be invaluable to Insulet as we continue to grow our core insulin pump business and expand into new opportunities for the easy-to-use OmniPod System."

Mr. Devlin spent the last 11 years at Abbott Laboratories, most recently serving as Divisional Vice President of Global Strategic Marketing, Diabetes Care. In this role, he was responsible for the development of commercial strategies, global brand management, market research, area strategic marketing, and business analytics and forecasting. Previously, Mr. Devlin served as Marketing Manager of i-STAT Corporation, a point-of-care blood analysis systems company, which was acquired by Abbott. Prior, Mr. Devlin spent eight years at C.R. Bard Inc., where he held various product management and engineering roles of increasing responsibility. Mr. Devlin holds a Bachelor of Science degree in Mechanical Engineering from the University of Massachusetts.

"I am eager to join Insulet at this exciting time as the OmniPod System transitions from being a new technology to the standard of care in the insulin pump market," said Mr. Devlin. "I am also excited to help Insulet realize the promise of its innovative delivery system in a broad range of therapies."

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Contact:
    Stephanie Marks for Insulet Corporation
    ir@insulet.com
    877-PODD-IR1 (877-763-3471)


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Corporation to Present at Upcoming Investor Conferences
2. Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday, August 4, 2009
3. Insulet Establishes Eco-Friendly Disposal Program for the OmniPod(R) Insulin Management System
4. Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships
5. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
6. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
7. Insulet Receives $60 Million Funding Commitment
8. Insulet Reports Fourth Quarter and Year End 2008 Results
9. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
10. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
11. Insulet Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
Breaking Medicine Technology: